PGEN
Precigen Inc
NASDAQ: PGEN · HEALTHCARE · BIOTECHNOLOGY
$4.12
+2.49% today
Updated 2026-04-29
Market cap
$1.46B
P/E ratio
—
P/S ratio
150.58x
EPS (TTM)
$-1.37
Dividend yield
—
52W range
$1 – $5
Volume
4.7M
Precigen Inc (PGEN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $8.01M | $13.93M | $23.76M | $71.93M | $173.60M | $190.93M | $230.98M | $160.57M | $31.99M | $31.99M | $14.27M | $26.91M | $6.22M | $3.92M | $9.68M |
| Revenue growth (YoY) | — | +73.8% | +70.6% | +202.7% | +141.4% | +10.0% | +21.0% | -30.5% | -80.1% | +0.0% | -55.4% | +88.6% | -76.9% | -36.9% | +146.7% |
| Cost of revenue | — | $64.03M | $48.16M | $19.26M | $63.93M | $61.64M | $62.79M | $63.29M | $5.37M | $44.80M | $53.68M | $6.34M | $6.12M | $4.27M | $6.10M |
| Gross profit | $8.01M | $-50.11M | $-24.41M | $52.67M | $109.68M | $129.29M | $168.19M | $97.29M | $26.62M | $-12.81M | $-39.41M | $20.57M | $106000.00 | $-342000.00 | $3.59M |
| Gross margin | 100.0% | -359.8% | -102.7% | 73.2% | 63.2% | 67.7% | 72.8% | 60.6% | 83.2% | -40.0% | -276.2% | 76.4% | 1.7% | -8.7% | 37.1% |
| R&D | $70.23M | $64.19M | $48.16M | $58.98M | $147.48M | $112.14M | $143.21M | $404.59M | $39.43M | $39.43M | $47.93M | $47.17M | $48.61M | $53.07M | $41.33M |
| SG&A | — | $24.90M | $33.62M | $63.65M | $109.06M | $142.32M | $146.10M | $137.81M | $100.84M | $91.70M | $74.12M | $48.01M | $40.41M | $41.29M | $70.13M |
| Operating income | $-82.43M | $-75.16M | $-58.02M | $-69.96M | $-146.86M | $-125.17M | $-137.89M | $-505.61M | $-86.32M | $-86.32M | $-91.95M | $-75.73M | $-99.76M | $-135.03M | $-106.60M |
| Operating margin | -1028.7% | -539.7% | -244.2% | -97.3% | -84.6% | -65.6% | -59.7% | -314.9% | -269.8% | -269.8% | -644.5% | -281.4% | -1602.5% | -3440.2% | -1100.8% |
| EBITDA | $-80.76M | $-73.83M | $-33.56M | $-74.64M | $-67.99M | $-168.72M | $-97.94M | $-349.06M | $-68.80M | $-67.99M | $-77.64M | $-62.43M | $-89.23M | $-123.50M | $-103.40M |
| EBITDA margin | -1007.8% | -530.2% | -141.3% | -103.8% | -39.2% | -88.4% | -42.4% | -217.4% | -215.1% | -212.5% | -544.2% | -232.0% | -1433.3% | -3146.4% | -1067.8% |
| EBIT | $-85.10M | $-81.82M | $-40.77M | $-85.05M | $-85.73M | $-193.29M | $-129.09M | $-373.16M | $-86.31M | $-85.50M | $-91.41M | $-73.19M | $-95.89M | $-128.02M | $-106.60M |
| Interest expense | $183000.00 | $57000.00 | $141000.00 | $666000.00 | $1.24M | $861000.00 | $611000.00 | $8.53M | $18.21M | $18.40M | $18.75M | $6.77M | $468000.00 | $6000.00 | $3.87M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-85.28M | $-81.87M | $-38.98M | $-81.82M | $-84.49M | $-186.61M | $-117.02M | $-509.34M | $-170.52M | $-170.52M | $-92.17M | $28.32M | $-95.90M | $-126.23M | $-250.64M |
| Net income growth (YoY) | — | +4.0% | +52.4% | -109.9% | -3.3% | -120.9% | +37.3% | -335.3% | +66.5% | +0.0% | +46.0% | +130.7% | -438.7% | -31.6% | -98.6% |
| Profit margin | -1064.3% | -588.0% | -164.1% | -113.8% | -48.7% | -97.7% | -50.7% | -317.2% | -533.0% | -533.0% | -646.0% | 105.2% | -1540.6% | -3216.2% | -2588.2% |